EcoDrugPlus

Ribosomal Protein L3

Ensembl ID : ENSIPUG00000010685
Gene Symbol: RPL3
3 Cross references
335 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSIPUG00000001810
Gene Symbol: RPL30
2 Cross references
415 Possible Orthologues:

Ribosomal Protein L31

Ensembl ID : ENSIPUG00000005147
Gene Symbol: RPL31
3 Cross references
651 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSIPUG00000019685
Gene Symbol: RPL34
3 Cross references
362 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSIPUG00000022186
Gene Symbol: RPL35
2 Cross references
265 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSIPUG00000013354
Gene Symbol: LOC124626769
3 Cross references
452 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSIPUG00000024935
Gene Symbol: RPL36
2 Cross references
394 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSIPUG00000005347
Gene Symbol: RPL37
3 Cross references
432 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSIPUG00000000953
Gene Symbol: RPL38
3 Cross references
193 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSIPUG00000019288
Gene Symbol: RPL39
3 Cross references
543 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSIPUG00000021502
Gene Symbol: LOC100304519
3 Cross references
344 Possible Orthologues:

Ribosomal Protein L5a

Ensembl ID : ENSIPUG00000013466
Gene Symbol: RPL5A
3 Cross references
521 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).